GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » Gross-Profit-to-Asset %

Bukwang Pharmaceutical Co (XKRX:003000) Gross-Profit-to-Asset % : 22.42% (As of Mar. 2025)


View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bukwang Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ₩83,589 Mil. Bukwang Pharmaceutical Co's average Total Assets over the quarter that ended in Mar. 2025 was ₩372,912 Mil. Therefore, Bukwang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 22.42%.


Bukwang Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Bukwang Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bukwang Pharmaceutical Co Gross-Profit-to-Asset % Chart

Bukwang Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.15 18.98 19.90 11.34 18.53

Bukwang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.72 17.66 23.23 23.68 22.42

Competitive Comparison of Bukwang Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Bukwang Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bukwang Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bukwang Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bukwang Pharmaceutical Co's Gross-Profit-to-Asset % falls into.


;
;

Bukwang Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Bukwang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=74343.168/( (429017.049+373180.312)/ 2 )
=74343.168/401098.6805
=18.53 %

Bukwang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=83588.608/( (373180.312+372643.445)/ 2 )
=83588.608/372911.8785
=22.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bukwang Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bukwang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR
Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co Headlines

No Headlines